A closer look at Replimune Group Inc (REPL)’s stock price trends

Patricia Turner

While Replimune Group Inc has underperformed by -0.34%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, REPL fell by -27.83%, with highs and lows ranging from $17.00 to $2.68, whereas the simple moving average jumped by 3.32% in the last 200 days.

On November 03, 2025, BMO Capital Markets Upgraded Replimune Group Inc (NASDAQ: REPL) to Market Perform. A report published by H.C. Wainwright on October 27, 2025, Upgraded its rating to ‘Buy’ for REPL. Wedbush also Upgraded REPL shares as ‘Outperform’, setting a target price of $18 on the company’s shares in a report dated October 20, 2025. Leerink Partners October 20, 2025d its ‘Market Perform’ rating to ‘Outperform’ for REPL, as published in its report on October 20, 2025. JP Morgan also rated the stock as ‘Underweight’.

Analysis of Replimune Group Inc (REPL)

There are several well-rounded types of analysis and research techniques that can be used to gain a clear view of Replimune Group Inc’s future performance, with equity being one of the most critical indicators. The goal here is to ensure that your current return on equity of -96.24% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 6.31, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

As an indicator of volatility for any stock, average volume can also be very valuable, and REPL is recording an average volume of 5.10M. On a monthly basis, the volatility of the stock is set at 8.39%, whereas on a weekly basis, it is put at 7.12%, with a loss of -4.27% over the past seven days. Furthermore, long-term investors anticipate a median target price of $12.57, showing growth from the present price of $8.74, which can serve as yet another indication of whether REPL is worth investing in or should be passed over.

How Do You Analyze Replimune Group Inc Shares?

Apart from looking at the fundamentals, you should also pay attention to the number of company employees who own shares. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 15.01%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 100.35% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.